English | Español
Patient Daily | Jul 31, 2026

Capricor CEO considers legal action after FDA panel votes against DMD therapy
Patient Daily | Jul 31, 2026

Alnylam cuts full-year guidance for TTR franchise, loses $10.8 billion in market value
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
Patient Daily | Jul 30, 2026

Microbial metabolites may improve functional cure rates for hepatitis B
Patient Daily | Jul 30, 2026

NYU Langone and Dana-Farber launch new oncology platform to support cancer care
Patient Daily | Jul 30, 2026

Dual immunotherapy with chemotherapy shows activity in HER2-negative breast cancer trial
Patient Daily | Jul 30, 2026

Texas A&M researchers develop AI tools to streamline tuberculosis drug discovery process
Patient Daily | Jul 30, 2026

FDA advisory committee votes in favor of Replimune’s melanoma therapy despite data concerns

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes